LEADER 03913nam 2200733Ia 450 001 9910966685803321 005 20251017110209.0 010 $a9786612454844 010 $a9780309148740 010 $a030914874X 010 $a9781282454842 010 $a1282454846 010 $a9780309130455 010 $a030913045X 035 $a(CKB)2550000000010224 035 $a(EBL)3378570 035 $a(SSID)ssj0000410972 035 $a(PQKBManifestationID)11293010 035 $a(PQKBTitleCode)TC0000410972 035 $a(PQKBWorkID)10351764 035 $a(PQKB)10755782 035 $a(MiAaPQ)EBC3378570 035 $a(Au-PeEL)EBL3378570 035 $a(CaPaEBR)ebr10364020 035 $a(CaONFJC)MIL245484 035 $a(OCoLC)923280829 035 $a(Perlego)4739481 035 $a(DNLM)1525250 035 $a(EXLCZ)992550000000010224 100 $a20090930d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAddressing the threat of drug-resistant tuberculosis $ea realistic assessment of the challenge : workshop summary /$fRobert Giffin and Sally Robinson, rapporteurs; Institute of Medicine of the National Academies 205 $a1st ed. 210 $aWashington, D.C. $cNational Academies Press$d2009 215 $a1 online resource (253 p.) 300 $a"The Institute of Medicine's (IOM's) Forum on Drug Discovery, Development, and Translation held a workshop in Washington, DC, on November 5, 2008"--p. 2. 311 08$a9780309130448 311 08$a0309130441 320 $aIncludes bibliographical references. 327 $aReviewers -- Contents -- Tables, Figures, and Boxes -- Acronyms -- Summary -- Chapter 1. Introduction -- Chapter 2. The Global Spread of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis -- Chapter 3. MDR TB Transmission, HIV Coinfection, and Transmission Control -- Chapter 4. Diagnosis -- Chapter 6. Infrastructure and Health Care Delivery Systems -- 6 Global Systems for the Purchase and Delivery of TB Drugs -- Chapter 7. Research on the Global Control of TB: Understanding the Role of Drugs, Vaccines, and Funding -- Chapter 8. Strategies for Confronting the Global MDR and XDR TB Crisis -- References. -- Appendix A: Agenda -- Appendix B: Participant Biographies -- Appendix C: Partners In Health White Paper' stemming the Tide of Multidrug-Resistant Tuberculosis: Major Barriers to Addressing the Growing Epidemic -- 330 $a"Tuberculosis is one of the leading causes of death in the world today, with 4,500 people dying from the disease every day. Many cases of TB can be cured by available antibiotics, but some TB is resistant to multiple drugs--a major and growing threat worldwide. The Institute of Medicine's Forum on Drug Discovery, Development, and Translation hosted a workshop on November 5, 2008, to address the mounting concern of drug-resistant TB. The session brought together a wide range of international experts to discuss what is known and not known about this growing threat, and to explore possible solutions."--Publisher's website. 606 $aMultidrug-resistant tuberculosis$vCongresses 606 $aTuberculosis$vCongresses 606 $aDrug resistance$vCongresses 606 $aAntitubercular agents$vCongresses 615 0$aMultidrug-resistant tuberculosis 615 0$aTuberculosis 615 0$aDrug resistance 615 0$aAntitubercular agents 676 $a616.9 701 $aGiffin$b Robert B$01806072 701 $aRobinson$b Sally$0620917 712 02$aInstitute of Medicine (U.S.).$bForum on Drug Discovery, Development, and Translation. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910966685803321 996 $aAddressing the threat of drug-resistant tuberculosis$94355011 997 $aUNINA